https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-may-2021-w-non-gaap-recs.pdf
That’s Avient. 21,000+ CUSTOMERS >75% ARE CUSTOMIZED SOLUTIONS TO UNIQUE SPECIFICATIONS of sales 5 In July 2020, we completed the acquisition of the Clariant Masterbatch business, the largest acquisition in the 20-year history of our company.
Our free cash flow supports shareholder value creation through investing in R&D for organic growth, completing bolt-on acquisitions, and returning cash to shareholders via our dividend program and opportunistic share repurchases. 27 1.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 A vi en t K W R A V Y R P M P P G G C P F U L A L B H X L E C L IF F F M C B N R A S H G R A F O E S C L E M N U N V R C E K R A H U N Median: 11.1xMedian: 14.8x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2022-02/AVNT Q4 2021 Earnings Presentation_0.pdf
Unless otherwise stated, Adjusted Operating Income, Adjusted EBITDA and Adjusted EPS figures included in this presentation exclude the impact of special items as defined in our quarterly earnings releases. 2021 PE RF O RM AN CE $80 $85 2020 2021 $0.52 $0.58 2020 2021 Q4 2021 PERFORMANCE (TOTAL COMPANY) 4 Sales Adjusted Operating Income $997 $1,202 2020 2021 + 21% Adjusted EPS + 6% + 12% (in millions) (in millions) $308 $429 2020PF 2021 $1.93 $3.05 2020PF 2021 FULL YEAR 2021 PERFORMANCE (TOTAL COMPANY) 5 Sales Adjusted Operating Income $3,783 $4,819 2020PF 2021 + 27% Adjusted EPS + 39% + 58% (in millions) (in millions) (1) Financial information is pro forma to include a full year of Clariant Color business (1) (1) (1) FULL YEAR 2021 SEGMENT PERFORMANCE 6 CAI $2,043 $2,402 Sales ($ in millions) SEM Distribution $226 $303 Operating Income + 18% + 34% $1,110 $1,631 Sales $70 $93 Operating Income + 47% + 33% (1) $709 $919 Sales $94 $132 Operating Income + 30% + 40% (1) Financial information is pro forma to include a full year of Clariant Color business (1) Full Year 2020 (Pro forma) $3,783 $308 Sustainable Solutions 147 19% 60 Healthcare 143 28% 30 Composites 58 43% 29 Growth in Asia / LATAM 107 21% 26 Other 543 30% 58 Sub-total $4,781 26% $511 Wage Inflation and Overtime (39) Other Supply Chain Costs (15) COVID Response Applications (22) (12) Synergies 44 FX, Incentives, Other Employee Costs 60 (60) Full Year 2021 $4,819 27% $429 FULL YEAR 2021 SALES AND OPERATING INCOME (TOTAL COMPANY) 7 Sales Growth Rate Adjusted Operating Income$ millions (1) Financial information is pro forma to include a full year of Clariant Color business (1) Adjusted EBITDA 8 Full Year 2020 (Pro forma) $ 457 Demand 135 $ millions CAI: Price / Mix 158 Inflation (120) SEM: Price / Mix 84 Inflation (65) Distribution: Price / Mix 318 Inflation (304) Net Price Benefit 71 Wage Inflation and Overtime (39) Other Supply Chain Costs (15) COVID Response Applications (12) Synergies 44 Incentives, FX, Other Employee Costs (60) Full Year 2021 $ 581 (1) Financial information is pro forma to include a full year of Clariant Color business (1) • Demand impact driven by growth in key focus areas: sustainable solutions, healthcare, composites and growth in Asia / LATAM • Price increases more than offset raw material and supply chain impacts FULL YEAR 2021 EBITDA BRIDGE SPECIALTY EBITDA MARGIN EXPANSION 9 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Color business 15.3% 15.2% 16.2% 17.0% 2018 2019 2020 2021 14.8% 15.2% 17.6% 17.8% 2018 2019 2020 2021 (1) SEM • Record margins in 2021 despite unprecedented supply chain challenges • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Color synergy realization • Investments in composites and outdoor high performance applications drove growth and mix improvements • Acquisition of Clariant Color business significantly expanded presence in healthcare, packaging and consumer end markets • Strength of portfolio – double-digit annual EBITDA growth since acquisition • $54 million of synergies realized in 2021 • Acquisition completed on July 1, 2020 for $1.45 billion.
Our free cash flow supports shareholder value creation through investing in R&D for organic growth, completing bolt-on acquisitions, and returning cash to shareholders via our dividend program and opportunistic share repurchases. 27 1.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $635M and estimated CAPEX of $90M (excludes IT system upgrade of $25M and synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of February 15, 2022 86 89 85 80 76 76 89 85 79 78 76 76 76 70 69 63 8 A vi e nt K W R P P G F U L A V Y R P M F M C U N V R H U N B N R H X L E C L C E A S H E M N S C L A LB Source: Peer data per Bloomberg market data as of February 15, 2022 Total Enterprise Value / 2022E EBITDAWith the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets.
https://www.avient.com/sites/default/files/2023-01/Hydrocerol Chemical Foaming Agents for Injection Molding Technical Bulletin.pdf
Benefits of Hydrocerol™ Chemical Foaming Agents They are endothermic chemical foaming agents that provide the following benefits in the injection molding process: Chemical foaming agents versus other technologies PP T20 with physical foaming agent (PFA), large cell structures, thin outer cover layer PP T20 + 3% Hydrocerol concentrate, small cell structures, thick outer cover layer Photo source: Neue Materialen Bayreuth (GmbH) During the activation reaction, chemical foaming agents principally react in two ways: • exothermic • endothermic Exothermic CFAs release more energy during decomposition than needed for the reaction.
https://www.avient.com/sites/default/files/2022-03/Asia SEM Healthcare Product Selection Guide %281%29.pdf
PP OVERMOLDING HARDNESS REGULATORY STERILIZATION CHARACTERISTICS Dynaflex™ G2706 28A USP Class VI, ISO 10993, Food contact EtO Soft translucent grade, grippy feel Dynaflex™ G2711 43A USP Class VI, ISO 10993, Food contact EtO Highly colorable solution, grippy feel, low compression set Versaflex™ CL2242 & CL2250 42A/ 50A USP Class VI, ISO 10993, US Food contact EtO Clear boilable grades; ABS, PC bondable Versaflex™ G2705 N 60A USP Class VI, ISO 10993, Food contact EtO/Steam High resilience, low compression set Versaflex™ HC3810 20A-90A USP Class VI, ISO 10993 EtO General purpose, unfilled ABS, PC OVERMOLDING HARDNESS REGULATORY STERILIZATION CHARACTERISTICS Versaflex™ OM1040 40A USP Class VI, ISO 10993 EtO Translucent Versaflex™ OM3060 60A USP Class VI, ISO 10993 EtO Clear VERSAFLEX™ CL AND DYNAFLEX™ TPEs OVERMOLDING FOR ERGONOMICS • Adds good tactile surface with soft-touch feel • Available in a variety of color effects and textures • Improves grip, cushion, and comfort • Enhances functional performance like sealing properties, vibration damping, oxygen barrier, and scratch and abrasion resistance • Reduces assembly costs, good processability • Offers excellent adhesion to a wide range of substrates Applications: • Glucometers • Medical tools overmolds • Injector pens • Analysis devices VERSALLOY™ HC & VERSAFLEX™ HC TPEs SEALING & RESEALING • Rubbery feel and soft touch • No coring, good puncture, and resealability in static stoppers • Meets low coefficient of friction requirements in dynamic seals • Low extractables • Suitable to overmold onto polyolefins Applications: • Sealing and resealing septum • Seals and sanitary gaskets • Syringe plungers and tips MATERIAL DESCRIPTION HARDNESS REGULATORY STERILIZATION CHARACTERISTICS Versalloy™ HC 9210-45N 45A USP Class VI EtO Good processability, smooth surface aesthetics Versalloy™ HC 9210-55N 55A USP Class VI EtO Good processability, smooth surface aesthetics Versalloy™ HC 9210-70N 70A USP Class VI EtO Good processability, smooth surface aesthetics Versalloy™ HC 9220-43N 43A USP Class VI, ISO 10993-4/5 EtO Extrusion grade, high temperature resistance Versaflex™ HC 2110-35N 34A FDA, USP Class VI, ISO 10993 Autoclave EtO radiation Resealing, elevated comp set Versaflex™ HC 2110-57B 57A FDA, USP Class VI, ISO 10993 Autoclave EtO radiation Low stiction VERSAFLEX™ CL AND DYNAFLEX™ TPEs HIGH CLARITY GRADES WITHOUT PLASTICIZERS • Water clear grades formulated without phthalate plasticizers • Meets medical regulatory USP Class VI and ISO 10993-4,5 • Food contact and FDA compliant • Autoclave and radiation stable • Low extractable • High clarity (Haze 50 4.1, 100 4.5, 100 4, 70 6, 70 Tensile Modulus (MPa) 2200 2700 2600 2350 1820 1820 Flexural Strength (MPa) 80 90 104 86 68 68 Flexural Modulus (MPa) 2500 2700 2500 2300 1980 1590 HDT: 0.45, 1.8 (MPa) 110, 80 90, 80 100, 89 123, 100 123, 64 100, 70 UL-94 Rating @ 3.0 mm 5VA V-0 5VA V-0 HB V-0 UL-94 Rating @ 1.5 mm V-0 V-0 5VB V-0 HB V-0 UL-94 Rating @ 0.75 mm V-1 V-2 V-0 None None V-2 COMPETITIVE MATERIAL COMPARISON ENGINEERED POLYMER FORMULATIONS FOR HEALTHCARE TRILLIANT™ HC THERMOPLASTICS The family of Trilliant™ HC high-performance thermoplastics is formulated to meet the growing challenges of medical devices and equipment.
MATERIAL DESCRIPTION BASE RESIN Trilliant™ HC2020 Copolyester Trilliant™ HC8910/8920 Polyketone/ABS blend Trilliant™ HC2120 Tritan Trilliant™ HC3120 PC Trilliant™ HC5210 PP Trilliant™ HC6010 PA6 Trilliant™ HC6610 PA66 Trilliant™ GRV-NP-110-W PA12 TRILLIANT™ HC THERMOPLASTICS • Chemically resistant replacement for FR PC/ABS, FR PC/PET & FR COPE, providing UL 94 Yellow Card V-0 flame rating at 1.5 mm, V-1 at 0.75 mm thicknesses for a broad color spectrum • Outperforms PC/ABS, PC/PET and COPE in resistance to common disinfectants • Retains tensile strength after 72-hour exposure to common hospital disinfectants, and shows better long-term chemical resistance as compared to PC blends and COPE • Exhibits good impact and temperature resistance • Available in natural grades, standard medical colors, or custom pre-colored products Applications: • Medical device housings • MRI, X-ray, CT scanner components • Surgical instruments such as staplers, dissectors, scissors • Auto-injector pen TRILLIANT™ HC ELECTRICALLY CONDUCTIVE FORMULATIONS • Consistent conductivity ensures repeatable part performance and minimizes failures related to inconsistent electrical conductivity • High flow and easy processing facilitate filling of thin wall parts and multiple cavity tools, which enable faster cycle times and lower per-unit part costs • Superior durability reduces breakage and resultant scrap related costs • Less tendency to flash results in improved appearance and less fluid retention in or on the tip, thus driving greater accuracy and less potential for cross-contamination • High strength produces parts with greater stiffness and warp resistance, again minimizing scrap-related costs Applications: • Conductive pipette tips TEST TEMS SPECIFIC GRAVITY MELT FLOW RATE (230OC, 2.16KG) TENSILE STRENGTH FLEXURAL STRENGTH FLEXURAL MODULUS IMPACT STRENGTH NOTCHED, IZOD SURFACE RESISTIVITY Method ASTM D-792 ASTM D-1238 ASTM D-638 ASTM D-790 ASTM D-790 ASTM D-256 ASTM D-257 Unit -- g/10min MPa MPa MPa J/m Ohms/sq.
https://www.avient.com/sites/default/files/2020-08/complet-lft-internal-backpack-frame.pdf
MAJOR OUTDOOR RETAILER I N T E R N A L W I L D G A M E B A C K P A C K F R A M E • Simpler manufacturing process to enable higher volume production • Retain shape while carrying wild game load • Toughness to survive backcountry use • Easy cleaning after use • Lowered production cost by substituting injection molded composite for thermoset layup • Redesigned frame to meet higher structural load requirements • Integrated design features to ease cleaning and improve functionality Complēt™ Long Carbon Fiber PA66 Composite KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2023-05/complet-lft-moisture-resistant-watercraft-steering-column-application-snapshot.pdf
PERSONAL WATERCRAFT OEM S T E E R I N G C O L U M N • Similar strength performance to existing aluminum assembly • Withstand outdoor UV exposure • Weight reduction for improved performance • Corrosion and moisture resistance • Premium aesthetic • Provided a material that met application load requirements and allowed for part consolidation • Delivered confidence in changing material through design consultation, robust Mold Flow simulation support, and UV customization • Incorporated carbon fiber to support a marketing story Complēt™ Hybrid Moisture Resistant Composite KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
That’s Avient. 21,000+ CUSTOMERS >75% ARE CUSTOMIZED SOLUTIONS TO UNIQUE SPECIFICATIONS of sales 5 In July 2020, we completed the acquisition of the Clariant Masterbatch business, the largest acquisition in the 20-year history of our company.
Our free cash flow supports shareholder value creation through investing in R&D for organic growth, completing bolt-on acquisitions, and returning cash to shareholders via our dividend program and opportunistic share repurchases. 27 1.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.4 18.2 16.0 15.5 15.3 11.3 11.0 29.7 26.5 23.5 18.2 13.4 11.9 11.9 11.7 10.5 10.4 10.3 10.1 9.7 7.7 6.5 A vi en t K W R A V Y P P G R P M F U L G C P H X L A L B E C L IF F F M C B N R A S H G R A E M N F O E S C L U N V R C E K R A H U N Median: 11.7xMedian: 15.4x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2021-11/avnt-november-investor-meetings.pdf
That’s Avient. 21,000+ CUSTOMERS >75% ARE CUSTOMIZED SOLUTIONS TO UNIQUE SPECIFICATIONS of sales 5 In July 2020, we completed the acquisition of the Clariant Color business, the largest acquisition in the 20-year history of our company.
Our free cash flow supports shareholder value creation through investing in R&D for organic growth, completing bolt-on acquisitions, and returning cash to shareholders via our dividend program and opportunistic share repurchases. 32 1.
With the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 33 Avient reflects 2021 estimated EBITDA of $580M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 11.4 20.2 16.7 16.5 14.7 12.0 10.8 40.7 29.9 26.2 13.2 12.4 11.0 10.9 9.1 9.0 7.5 6.5 A vi en t K W R P P G A V Y R P M F U L G C P A L B H X L E C L A S H F M C B N R S C L U N V R E M N C E H U N SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/resources/safety-data-sheets?page=495
PP 554CS NAT-15 WM
You may enter COMPLETE or PARTIAL product code or name information.
GEON W9300 NAT 0000
https://www.avient.com/resources/safety-data-sheets?page=1804
GRV-NJ-045-W-NAT
X155080335 EXPWJCK502L NAT
GEON W9300 NAT 0000